Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 220

1.

Tissue-engineered, hydrogel-based endothelial progenitor cell therapy robustly revascularizes ischemic myocardium and preserves ventricular function.

Atluri P, Miller JS, Emery RJ, Hung G, Trubelja A, Cohen JE, Lloyd K, Han J, Gaffey AC, MacArthur JW, Chen CS, Woo YJ.

J Thorac Cardiovasc Surg. 2014 Sep;148(3):1090-7; discussion 1097-8. doi: 10.1016/j.jtcvs.2014.06.038. Epub 2014 Jun 28.

2.

Injectable shear-thinning hydrogels used to deliver endothelial progenitor cells, enhance cell engraftment, and improve ischemic myocardium.

Gaffey AC, Chen MH, Venkataraman CM, Trubelja A, Rodell CB, Dinh PV, Hung G, MacArthur JW, Soopan RV, Burdick JA, Atluri P.

J Thorac Cardiovasc Surg. 2015 Nov;150(5):1268-76. doi: 10.1016/j.jtcvs.2015.07.035. Epub 2015 Jul 17.

3.

Epicardial adipose stem cell sheets results in greater post-infarction survival than intramyocardial injections.

Hamdi H, Planat-Benard V, Bel A, Puymirat E, Geha R, Pidial L, Nematalla H, Bellamy V, Bouaziz P, Peyrard S, Casteilla L, Bruneval P, Hagège AA, Agbulut O, Menasché P.

Cardiovasc Res. 2011 Aug 1;91(3):483-91. doi: 10.1093/cvr/cvr099. Epub 2011 May 12.

PMID:
21565832
4.

Tissue-engineered pro-angiogenic fibroblast scaffold improves myocardial perfusion and function and limits ventricular remodeling after infarction.

Fitzpatrick JR 3rd, Frederick JR, McCormick RC, Harris DA, Kim AY, Muenzer JR, Gambogi AJ, Liu JP, Paulson EC, Woo YJ.

J Thorac Cardiovasc Surg. 2010 Sep;140(3):667-76. doi: 10.1016/j.jtcvs.2009.12.037. Epub 2010 Apr 3.

5.

Normalization of postinfarct biomechanics using a novel tissue-engineered angiogenic construct.

Atluri P, Trubelja A, Fairman AS, Hsiao P, MacArthur JW, Cohen JE, Shudo Y, Frederick JR, Woo YJ.

Circulation. 2013 Sep 10;128(11 Suppl 1):S95-104. doi: 10.1161/CIRCULATIONAHA.112.000368.

6.

Expanded human cord blood-derived endothelial progenitor cells salvage infarcted myocardium in rats with acute myocardial infarction.

Hu CH, Li ZM, Du ZM, Zhang AX, Rana JS, Liu DH, Yang DY, Wu GF.

Clin Exp Pharmacol Physiol. 2010 May;37(5-6):551-6. doi: 10.1111/j.1440-1681.2010.05347.x.

PMID:
20529094
7.

Sustained release of engineered stromal cell-derived factor 1-α from injectable hydrogels effectively recruits endothelial progenitor cells and preserves ventricular function after myocardial infarction.

MacArthur JW Jr, Purcell BP, Shudo Y, Cohen JE, Fairman A, Trubelja A, Patel J, Hsiao P, Yang E, Lloyd K, Hiesinger W, Atluri P, Burdick JA, Woo YJ.

Circulation. 2013 Sep 10;128(11 Suppl 1):S79-86. doi: 10.1161/CIRCULATIONAHA.112.000343.

8.

Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells.

Xiong Q, Ye L, Zhang P, Lepley M, Swingen C, Zhang L, Kaufman DS, Zhang J.

Circ Res. 2012 Aug 3;111(4):455-68. doi: 10.1161/CIRCRESAHA.112.269894. Epub 2012 Jun 21.

9.

Alignment of inducible vascular progenitor cells on a micro-bundle scaffold improves cardiac repair following myocardial infarction.

Jamaiyar A, Wan W, Ohanyan V, Enrick M, Janota D, Cumpston D, Song H, Stevanov K, Kolz CL, Hakobyan T, Dong F, Newby BZ, Chilian WM, Yin L.

Basic Res Cardiol. 2017 Jul;112(4):41. doi: 10.1007/s00395-017-0631-4. Epub 2017 May 24.

PMID:
28540527
10.

Sustained release of endothelial progenitor cell-derived extracellular vesicles from shear-thinning hydrogels improves angiogenesis and promotes function after myocardial infarction.

Chen CW, Wang LL, Zaman S, Gordon J, Arisi MF, Venkataraman CM, Chung JJ, Hung G, Gaffey AC, Spruce LA, Fazelinia H, Gorman RC, Seeholzer SH, Burdick JA, Atluri P.

Cardiovasc Res. 2018 Jun 1;114(7):1029-1040. doi: 10.1093/cvr/cvy067.

11.

Comparative effects of mesenchymal progenitor cells, endothelial progenitor cells, or their combination on myocardial infarct regeneration and cardiac function.

Suuronen EJ, Price J, Veinot JP, Ascah K, Kapila V, Guo XW, Wong S, Mesana TG, Ruel M.

J Thorac Cardiovasc Surg. 2007 Nov;134(5):1249-58.

12.

Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.

Huang J, Zhang Z, Guo J, Ni A, Deb A, Zhang L, Mirotsou M, Pratt RE, Dzau VJ.

Circ Res. 2010 Jun 11;106(11):1753-62. doi: 10.1161/CIRCRESAHA.109.196030. Epub 2010 Apr 8.

13.

Spliced stromal cell-derived factor-1α analog stimulates endothelial progenitor cell migration and improves cardiac function in a dose-dependent manner after myocardial infarction.

Hiesinger W, Frederick JR, Atluri P, McCormick RC, Marotta N, Muenzer JR, Woo YJ.

J Thorac Cardiovasc Surg. 2010 Nov;140(5):1174-80. doi: 10.1016/j.jtcvs.2010.08.012.

14.

Stromal cell-derived factor-1alpha activation of tissue-engineered endothelial progenitor cell matrix enhances ventricular function after myocardial infarction by inducing neovasculogenesis.

Frederick JR, Fitzpatrick JR 3rd, McCormick RC, Harris DA, Kim AY, Muenzer JR, Marotta N, Smith MJ, Cohen JE, Hiesinger W, Atluri P, Woo YJ.

Circulation. 2010 Sep 14;122(11 Suppl):S107-17. doi: 10.1161/CIRCULATIONAHA.109.930404.

15.

Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function.

Zakharova L, Mastroeni D, Mutlu N, Molina M, Goldman S, Diethrich E, Gaballa MA.

Cardiovasc Res. 2010 Jul 1;87(1):40-9. doi: 10.1093/cvr/cvq027. Epub 2010 Jan 29.

16.

Ultrasound-targeted gene delivery induces angiogenesis after a myocardial infarction in mice.

Fujii H, Sun Z, Li SH, Wu J, Fazel S, Weisel RD, Rakowski H, Lindner J, Li RK.

JACC Cardiovasc Imaging. 2009 Jul;2(7):869-79. doi: 10.1016/j.jcmg.2009.04.008.

17.

Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine.

Gao L, Gregorich ZR, Zhu W, Mattapally S, Oduk Y, Lou X, Kannappan R, Borovjagin AV, Walcott GP, Pollard AE, Fast VG, Hu X, Lloyd SG, Ge Y, Zhang J.

Circulation. 2018 Apr 17;137(16):1712-1730. doi: 10.1161/CIRCULATIONAHA.117.030785. Epub 2017 Dec 12.

18.

Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells.

Quijada P, Toko H, Fischer KM, Bailey B, Reilly P, Hunt KD, Gude NA, Avitabile D, Sussman MA.

Circ Res. 2012 Jun 22;111(1):77-86. doi: 10.1161/CIRCRESAHA.112.265207. Epub 2012 May 22.

19.

Transplantation of endothelial progenitor cells improves neovascularization and left ventricular function after myocardial infarction in a rat model.

Schuh A, Liehn EA, Sasse A, Hristov M, Sobota R, Kelm M, Merx MW, Weber C.

Basic Res Cardiol. 2008 Jan;103(1):69-77. Epub 2007 Nov 12.

PMID:
17999028
20.

Composite scaffold provides a cell delivery platform for cardiovascular repair.

Godier-Furnémont AF, Martens TP, Koeckert MS, Wan L, Parks J, Arai K, Zhang G, Hudson B, Homma S, Vunjak-Novakovic G.

Proc Natl Acad Sci U S A. 2011 May 10;108(19):7974-9. doi: 10.1073/pnas.1104619108. Epub 2011 Apr 20.

Supplemental Content

Support Center